BioLife Solutions Announces the Sale of its evo Cold Chain Logistics Subsidiary

Core Insights - BioLife Solutions, Inc. has announced the sale of its wholly owned cold chain logistics subsidiary, SAVSU Cleo Technologies, LLC, for $25.5 million in cash to Peli BioThermal, enhancing its focus on high-margin recurring revenue [1][2]. Company Overview - BioLife Solutions is a leading developer and supplier of cell processing tools and services for the cell and gene therapy market, facilitating the commercialization of new therapies by providing solutions that maintain the health and function of biologic materials during various stages [2].